Early stroke and systemic embolism rates in patients following cardioversion for atrial fibrillation (A-fib) are low and comparable between those receiving warfarin or the novel oral anticoagulant ...
ANKARA, TURKEY — A strategy that takes advantage of the C in ICD (implantable cardioverter defibrillator), in which the device delivers a shock aimed at restoring sinus rhythm in patients with atrial ...
Please provide your email address to receive an email when new articles are posted on . In patients with atrial fibrillation undergoing cardioversion, edoxaban conferred similar outcomes to the ...
Smartphone-based heart rhythm monitoring from home can reduce same-day cancellations and help save significant health care ...
Smartphone-based heart rhythm monitoring from home can reduce same-day cancellations and help save significant healthcare ...
Oral anticoagulant therapy with rivaroxaban is a safe alternative to Vitamin K antagonist (VKA) therapy in patients with atrial fibrillation who are undergoing elective cardioversion to restore a ...
Patients with atrial fibrillation (AF) who need anticoagulation before undergoing electrical correction of their abnormal heartbeat (cardioversion) may benefit from treatment with edoxoban - a ...
A delay of 12 hours or longer to correct an abnormal cardiac rhythm from atrial fibrillation was associated with a greater risk of thromboembolic complications such as stroke, according to a study. A ...
Nicholas P. Gall, M.Sc., M.D., M.R.C.P.; Francis D. Murgatroyd, M.A., F.R.C.P., F.A.C.C. From these and subsequent studies, it became clear that cardioversion was ...